DexCom
DXCM
#903
Rank
NZ$44.73 B
Marketcap
NZ$114.71
Share price
1.48%
Change (1 day)
-6.36%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2024: NZ$1.24 Billion

According to DexCom's latest financial reports the company's current earnings are NZ$4.51 Billion. In 2024 the company made an earning of NZ$1.24 Billion a decrease over its 2023 earnings that were of NZ$1.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2024

Annual earnings

Year Earnings Change
2024NZ$1.24 B-0.37%
2023NZ$1.24 B78.13%
2022NZ$0.69 B47.34%
2021NZ$0.47 B-10.11%
2020NZ$0.52 B88.27%
2019NZ$0.28 B-258.48%
2018-NZ$0.18 Billion189.94%
2017-NZ$61 Million-44.24%
2016-NZ$0.11 Billion12.43%
2015-NZ$97.3 Million165.58%
2014-NZ$36.64 Million-25.61%
2013-NZ$49.25 Million-48.11%
2012-NZ$94.91 Million24.5%
2011-NZ$76.23 Million
2008-NZ$90.02 Million13.18%
2007-NZ$79.54 Million-5.36%
2006-NZ$84.04 Million52.08%
2005-NZ$55.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$55.19 B 3,212.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.86 B 732.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$10.92 B 555.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
NZ$3.20 B 92.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
NZ$2.90 B 74.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.35 Billion-120.95%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-NZ$1.94 Billion-216.18%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
NZ$1.02 B-38.21%๐Ÿ‡บ๐Ÿ‡ธ USA